Defining clinical subgroups and genotype-phenotype correlations in NBAS-associated disease across 110 patients.


Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
03 2020
Historique:
received: 09 08 2019
accepted: 30 10 2019
revised: 30 10 2019
pubmed: 26 11 2019
medline: 4 2 2021
entrez: 26 11 2019
Statut: ppublish

Résumé

Pathogenic variants in neuroblastoma-amplified sequence (NBAS) cause an autosomal recessive disorder with a wide range of symptoms affecting liver, skeletal system, and brain, among others. There is a continuously growing number of patients but a lack of systematic and quantitative analysis. Individuals with biallelic variants in NBAS were recruited within an international, multicenter study, including novel and previously published patients. Clinical variables were analyzed with log-linear models and visualized by mosaic plots; facial profiles were investigated via DeepGestalt. The structure of the NBAS protein was predicted using computational methods. One hundred ten individuals from 97 families with biallelic pathogenic NBAS variants were identified, including 26 novel patients with 19 previously unreported variants, giving a total number of 86 variants. Protein modeling redefined the β-propeller domain of NBAS. Based on the localization of missense variants and in-frame deletions, three clinical subgroups arise that differ significantly regarding main clinical features and are directly related to the affected region of the NBAS protein: β-propeller (combined phenotype), Sec39 (infantile liver failure syndrome type 2/ILFS2), and C-terminal (short stature, optic atrophy, and Pelger-Huët anomaly/SOPH). We define clinical subgroups of NBAS-associated disease that can guide patient management and point to domain-specific functions of NBAS.

Identifiants

pubmed: 31761904
doi: 10.1038/s41436-019-0698-4
pii: S1098-3600(21)01261-2
doi:

Substances chimiques

NBAS protein, human 0
Neoplasm Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

610-621

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK109907
Pays : United States
Organisme : Wellcome Trust
ID : 10585/B/18/Z
Pays : United Kingdom

Références

Maksimova N, Hara K, Nikolaeva I, et al. Neuroblastoma amplified sequence gene is associated with a novel short stature syndrome characterised by optic nerve atrophy and Pelger-Huet anomaly. J Med Genet. 2010;47:538–548.
pubmed: 20577004 pmcid: 2921285
Haack TB, Staufner C, Kopke MG, et al. Biallelic mutations in NBAS cause recurrent acute liver failure with onset in infancy. Am J Hum Genet. 2015;97:163–169.
pubmed: 26073778 pmcid: 4572578
Staufner C, Haack TB, Kopke MG, et al. Recurrent acute liver failure due to NBAS deficiency: phenotypic spectrum, disease mechanisms, and therapeutic concepts. J Inherit Metab Dis. 2016;39:3–16.
pubmed: 26541327
Kortum F, Marquardt I, Alawi M, et al. Acute liver failure meets SOPH syndrome: a case report on an intermediate phenotype. Pediatrics. 2017;139:e20160550.
pubmed: 28031453
Segarra NG, Ballhausen D, Crawford H, et al. NBAS mutations cause a multisystem disorder involving bone, connective tissue, liver, immune system, and retina. Am J Hum Genet A. 2015;167A:2902–2912.
Capo-Chichi JM, Mehawej C, Delague V, et al. Neuroblastoma Amplified Sequence (NBAS) mutation in recurrent acute liver failure: confirmatory report in a sibship with very early onset, osteoporosis and developmental delay. Eur J Med Genet. 2015;58:637–641.
pubmed: 26578240
Buote C Application clinique du séquençage de l’exome pour le diagnostic moléculaire des syndromes polymalformatifs, Sherbrooke, CA: Department of Biochemistry, University of Sherbrooke; 2015.
Haskins-Olney A. NBAS-related SOPH syndrome with immunodeficiency in a North American patient. Paper presented at: ACMG Annual Clinical Genetics Meeting; Tampa, FL; March 8–12, 2016.
Rothenbuhler A. NBAS mutations, a new monogenic cause of DISOPHAL, a new syndrome with type 1 diabetes (T1D). Paper presented at: 55th Annual European Society for Paediatric Endocrinology Meeting; Paris; September 10–12, 2016.
Balasubramanian M, Hurst J, Brown S, et al. Compound heterozygous variants in NBAS as a cause of atypical osteogenesis imperfecta. Bone. 2017;94:65–74.
pubmed: 27789416
Regateiro FS, Belkaya S, Neves N, et al. Recurrent elevated liver transaminases and acute liver failure in two siblings with novel bi-allelic mutations of NBAS. Eur J Med Genet. 2017;60:426–432.
pubmed: 28576691
Calvo PL, Tandoi F, Haak TB, et al. NBAS mutations cause acute liver failure: when acetaminophen is not a culprit. Ital J Pediatr. 2017;43:88.
pubmed: 28946922 pmcid: 5613325
Hasosah MY, Iskandarani AI, Shawli AI, Alsahafi AF, Sukkar GA, Qurashi MA. Neuroblastoma amplified sequence gene mutation: a rare cause of recurrent liver failure in children. Saudi J Gastroenterol. 2017;23:206–208.
pubmed: 28611345 pmcid: 5470381
Cardenas V, DiPaola F, Adams SD, Holtz AM, Ahmad A. Acute liver failure secondary to neuroblastoma amplified sequence deficiency. J Pediatr. 2017;186:179–182.
pubmed: 28410752
Li JQ, Qiu YL, Gong JY, et al. Novel NBAS mutations and fever-related recurrent acute liver failure in Chinese children: a retrospective study. BMC Gastroenterol. 2017;17:77.
pubmed: 28629372 pmcid: 5477288
Park JW, Lee SJ. Foveal hypoplasia in short stature with optic atrophy and Pelger-Huet anomaly syndrome with neuroblastoma-amplified sequence (NBAS) gene mutation. J AAPOS. 2017;22:334.
Kim YM, Lee YJ, Park JH, et al. High diagnostic yield of clinically unidentifiable syndromic growth disorders by targeted exome sequencing. Clin Genet. 2017;92:594–605.
pubmed: 28425089
He TY, Zhang N, Xia Y, Luo Y, Li CR, Yang J. [Short stature, optic nerve atrophy and Pelger-Huët anomaly syndrome with antibody immunodeficiency and aplastic anemia: a case report and literature review]. Zhonghua Er Ke Za Zhi. 2017;55:942–946.
pubmed: 29262476
Yao Q, Wu W, Luo X. SOPH syndrome causes recurrent acute liver failure with onset in infancy. Paper presented at: 13th International Congress of Inborn Errors of Metabolism (ICIEM); Rio de Janeiro; September 5–8, 2017.
Mungan N, Yildizdas D, Arikan C, et al. Recurrent acute liver failure in a family with NBAS gene mutation and successful liver transplantation: first cases from Turkey. Journal of Inborn Errors of Metabolism & Screening. 2017;5:399.
Yadav A, Hopkin RJ, Schorry EK. SOPH syndrome: multisystem disorder with facial dysmorphism, skeletal dysplasia, episodic liver failure, immune dysfunction and intellectual disability. Paper presented at: American Society of Human Genetics Meeting; Orlando, FL; October 17–21, 2017.
Wang J, Pu Z, Lu Z. Targeted nextgeneration sequencing reveals two novel mutations of NBAS in a patient with infantile liver failure syndrome 2. Mol Med Rep. 2018;17:2245–2250.
pubmed: 29207168
Sunwoo Y, Kim YM, Kim EN, Oh SH, Lee BH. Severe form of neuroblastoma amplified sequence deficiency in an infant with recurrent acute liver failure. Pediatr Int. 2018;60:302–304.
pubmed: 29575310
Palagano E, Zuccarini G, Prontera P, et al. Mutations in the neuroblastoma amplified sequence gene in a family affected by acrofrontofacionasal dysostosis type 1. Bone. 2018;114:125–136.
pubmed: 29929043
Li X, Cheng Q, Li N, et al. SOPH syndrome with growth hormone deficiency, normal bone age, and novel compound heterozygous mutations in NBAS. Fetal Pediatr Pathol. 2018;37:404–410.
pubmed: 30592236
Godinez-Zamora GF, Baeza-Capetillo P, Villaseñor-Dominguez A, et al. A novel mutation in NBAS causes SOPH syndrome. Paper presented at: American Society for Human Genetics Annual Meeting; San Diego, CA; October 16–20, 2018.
Konstantopoulou VK, Moeslinger DM, Goeschl BG, Roscher A. Severe hypoglycemia and seizures as the first signs in NBAS deficiency. J Inherit Metab Dis. 2018;41 (Suppl 1):S37–S219.
Thuriot F, Buote C, Gravel E, et al. Clinical validity of phenotype-driven analysis software PhenoVar as a diagnostic aid for clinical geneticists in the interpretation of whole-exome sequencing data. Genet Med. 2018;20:942–949.
pubmed: 29388948
Mallakmir S, Nagral A, Bagde A, Mirza D, Merchant R, Yewale V. Mutation in the neuroblastoma amplified sequence gene as a cause of recurrent acute liver failure, acute kidney injury, and status epilepticus. J Clin Exp Hepatol (in press).
Ranucci G, Lenz D, Staufner C, et al. Fever induced recurrent acute liver failure as a dominant feature in congenital disorders of intracellular trafficking. J Inherit Metab Dis. 2018;41 (Suppl 1):S37–S219.
Giatropoulou S, König R, Wudy SA, et al. NBAS gene mutation causes insulin-dependent diabetes mellitus in a patient with a multisystem disorder consisting immunodeficiency and extremely short stature. Paper presented at: 57th Annual Meeting of the European Society for Paediatric Endocrinology; Athens, Greece; September 27–29, 2018.
Rius R, Riley LG, Guo Y, et al. Cryptic intronic NBAS variant reveals the genetic basis of recurrent liver failure in a child. Mol Genet Metab. 2019;126:77–82.
pubmed: 30558828
Nucci F, Lembo A, Farronato M, Farronato G, Nucci P, Serafino M. Oculofacial alterations in NBAS-SOPH like mutations: case report. Eur J Ophthalmol. 2019;8:1120672119836335.
Ono S, Matsuda J, Watanabe E, et al. Novel neuroblastoma amplified sequence (NBAS) mutations in a Japanese boy with fever-triggered recurrent acute liver failure. Hum Genome Var. 2019;6:2.
pubmed: 30622725 pmcid: 6323122
Carli D, Giorgio E, Pantaleoni F, et al. NBAS pathogenic variants: defining the associated clinical and facial phenotype and genotype–phenotype correlations. Hum Mutat. 2019;40:721–728.
pubmed: 30825388
Fischer-Zirnsak B, Koenig R, Alisch F, et al. SOPH syndrome in three affected individuals showing similarities with progeroid cutis laxa conditions in early infancy. J Hum Genet. 2019;64:609–616.
pubmed: 31015584
Aoki T, Ichimura S, Itoh A, et al. Identification of the neuroblastoma-amplified gene product as a component of the syntaxin 18 complex implicated in Golgi-to-endoplasmic reticulum retrograde transport. Mol Biol Cell. 2009;20:2639–2649.
pubmed: 19369418 pmcid: 2688544
Raote I, Ortega-Bellido M, Santos AJ, et al. TANGO1 builds a machine for collagen export by recruiting and spatially organizing COPII, tethers and membranes. eLife. 2018;7:e32723.
pubmed: 29513218 pmcid: 5851698
Cousin MA, Conboy E, Wang JS, et al. RINT1 bi-allelic variations cause infantile-onset recurrent acute liver failure and skeletal abnormalities. Am J Hum Genet. 2019;105:108–121.
pubmed: 31204009 pmcid: 6612521
Lenz D, McClean P, Kansu A, et al. SCYL1 variants cause a syndrome with low gamma-glutamyl-transferase cholestasis, acute liver failure, and neurodegeneration (CALFAN). Genet Med. 2018;20:1255–1265.
pubmed: 29419818 pmcid: 5989927
Longman D, Hug N, Keith M, et al. DHX34 and NBAS form part of an autoregulatory NMD circuit that regulates endogenous RNA targets in human cells, zebrafish and Caenorhabditis elegans. Nucleic Acids Res. 2013;41:8319–8331.
pubmed: 23828042 pmcid: 3783168
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–424.
pubmed: 25741868 pmcid: 25741868
Renner C, Razeghi S, Richter T, Ueberall MA, Schless A. Metab-L: an electronic mailing list on inborn errors of metabolism. Acta Paediatr. 1997;86:892–894.
pubmed: 9307174
Gurovich Y, Hanani Y, Bar O, et al. Identifying facial phenotypes of genetic disorders using deep learning. Nat Med. 2019;25:60–64.
pubmed: 30617323
Zimmermann L, Stephens A, Nam SZ. et al. A completely reimplemented MPI Bioinformatics Toolkit with a nw HHpred server at its core. J Mol Biol. 2018;430:2237–2243.
pubmed: 29258817
Meszaros B, Erdos G, Dosztanyi Z. IUPred2A: context-dependent prediction of protein disorder as a function of redox state and protein binding. Nucleic Acids Res. 2018;46(W1):W329–W337.
pubmed: 29860432 pmcid: 6030935
Rozewicki J, Li S, Amada KM, Standley DM, Katoh K. MAFFT-DASH: integrated protein sequence and structural alignment. Nucleic Acids Res. 2019;47(W1):W5–W10.
pubmed: 31062021 pmcid: 6602451
Meyer D, Zeileis A, Hornik K. The Strucplot Framework: Visualizing Multi-way Contingency Tables with vcd. J Stat Softw. 2006;17:48.
South A. rworldmap: a new R package for mapping global data. R J. 2011;3:35–43.
Zhong Q, Simonis N, Li QR, et al. Edgetic perturbation models of human inherited disorders. Mol Syst Biol. 2009;5:321.
pubmed: 19888216 pmcid: 2795474
Drozdetskiy A, Cole C, Procter J, Barton GJ. JPred4: a protein secondary structure prediction server. Nucleic Acids Res. 2015;43(W1):W389–W394.
pubmed: 25883141 pmcid: 4489285
Dosztanyi Z, Csizmok V, Tompa P, Simon I. IUPred: web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content. Bioinformatics. 2005;21:3433–3434.
pubmed: 15955779
Ren Y, Yip CK, Tripathi A, et al. A structure-based mechanism for vesicle capture by the multisubunit tethering complex Dsl1. Cell. 2009;139:1119–1129.
pubmed: 20005805 pmcid: 2806190
Megarbane A, Samaras L, Chedid R, et al. Developmental delay, dysmorphic features, neonatal spontaneous fractures, wrinkled skin, and hepatic failure: a new metabolic syndrome? Am J Hum Genet A. 2008;146A:3198–3201.
Prontera P, Urciuoli R, Siliquini S, et al. Acrofrontofacionasal dysostosis 1 in two sisters of Indian origin. Am J Hum Genet A. 2011;155a:3125–3127.
van Dam TJ, Townsend MJ, Turk M, et al. Evolution of modular intraflagellar transport from a coatomer-like progenitor. Proc Natl Acad Sci U S A. 2013;110:6943–6948.
pubmed: 23569277 pmcid: 3637775
Aloy P, Russell RB. Interrogating protein interaction networks through structural biology. Proc Natl Acad Sci U S A. 2002;99:5896–5901.
pubmed: 11972061 pmcid: 122873
Stirnimann CU, Petsalaki E, Russell RB, Muller CW. WD40 proteins propel cellular networks. Trends Biochem Sci. 2010;35:565–574.
pubmed: 20451393
Gouw M, Michael S, Samano-Sanchez H, et al. The eukaryotic linear motif resource—2018 update. Nucleic Acids Res. 2018;46(D1):D428–D434.
pubmed: 29136216
Willison KR. The substrate specificity of eukaryotic cytosolic chaperonin CCT. Philos Trans R Soc Lond B Biol Sci. 2018;373:20170192.
pubmed: 29735743 pmcid: 5941184

Auteurs

Christian Staufner (C)

Division of Neuropediatrics and Pediatric Metabolic Medicine, Center for Child and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.

Bianca Peters (B)

Division of Neuropediatrics and Pediatric Metabolic Medicine, Center for Child and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.

Matias Wagner (M)

Institute of Human Genetics, Klinikum rechts der Isar, Technical University of Munich, Munich, Munich, Germany.
Institute of Human Genetics, Helmholtz Zentrum Munich, Neuherberg, Germany.
Institute of Neurogenomics, Helmholtz Zentrum München, Neuherberg, Germany.

Seham Alameer (S)

Department of Pediatrics, King Khaled National Guard Hospital, Jeddah, Saudi Arabia.

Ivo Barić (I)

Department of Pediatrics, University Hospital Center Zagreb and University of Zagreb, School of Medicine, Zagreb, Croatia.

Pierre Broué (P)

Pediatric Gastroenterology, Hepatology and Nutrition unit, Reference Center for Inherited Metabolic Diseases, Children's Hospital, Toulouse University Hospital, Toulouse, France.

Derya Bulut (D)

Cukurova University Medical Faculty, Department of Pediatric Metabolism, Adana, Turkey.

Joseph A Church (JA)

Department of Pediatrics, University of Southern California, Children's Hospital Los Angeles, Los Angeles, CA, USA.

Ellen Crushell (E)

National Centre for Inherited Metabolic Disorders, Temple Street Children's University Hospital, Dublin, Ireland.

Buket Dalgıç (B)

Gazi University Faculty of Medicine, Department of Pediatric Gastroenterology, Ankara, Turkey.

Anibh M Das (AM)

Clinic for Pediatric Kidney, Liver, and Metabolic Diseases, Hannover Medical School, Hannover, Germany.

Anke Dick (A)

Department of Pediatrics, University Hospital Würzburg, Wuerzburg, Germany.

Nicola Dikow (N)

Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.

Carlo Dionisi-Vici (C)

Division of Metabolism, Bambino Gesù Children's Hospital, Rome, Italy.

Felix Distelmaier (F)

Department of General Pediatrics, Neonatology and Pediatric Cardiology, University Children's Hospital, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

Neslihan Ekşi Bozbulut (NE)

Gazi University Faculty of Medicine, Department of Pediatric Gastroenterology, Ankara, Turkey.

François Feillet (F)

Department of Pediatrics, INSERM 1256, Hôpital d'Enfants Brabois, CHU Nancy, Vandoeuvre les Nancy, France.

Emmanuel Gonzales (E)

Pediatric Hepatology and Pediatric Liver Transplantation Unit, Bicêtre Hospital, AP-HP Paris-Sud University, Le Kremlin-Bicêtre, France.

Nedim Hadzic (N)

Pediatric Liver, GI and Nutrition Centre and Mowatlabs, King's College Hospital, London, UK.

Fabian Hauck (F)

Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Munich, Germany.

Robert Hegarty (R)

Pediatric Liver, GI and Nutrition Centre and Mowatlabs, King's College Hospital, London, UK.

Maja Hempel (M)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Theresia Herget (T)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Christoph Klein (C)

Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Munich, Germany.

Vassiliki Konstantopoulou (V)

Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.

Robert Kopajtich (R)

Institute of Human Genetics, Klinikum rechts der Isar, Technical University of Munich, Munich, Munich, Germany.
Institute of Human Genetics, Helmholtz Zentrum Munich, Neuherberg, Germany.

Alice Kuster (A)

Inborn Errors of Metabolism, Pediatric Intensive Care Unit, University Hospital of Nantes, Nantes, France.

Martin W Laass (MW)

Children's Hospital, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Elke Lainka (E)

Children's Hospital, Department of Pediatric Gastroenterology, Hepatology, and Transplant Medicine, University Duisburg-Essen, Essen, Germany.

Catherine Larson-Nath (C)

Pediatric Gastroenterology, University of Minnesota Medical School, Minneapolis, MN, USA.

Alexander Leibner (A)

Division of Neuropediatrics and Pediatric Metabolic Medicine, Center for Child and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.

Eberhard Lurz (E)

Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Munich, Germany.

Johannes A Mayr (JA)

Department of Pediatrics, Salzburger Landeskliniken and Paracelsus Medical University, Salzburg, Austria.

Patrick McKiernan (P)

University of Pittsburgh School of Medicine, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA.

Karine Mention (K)

Reference Center for Inherited Metabolic Diseases, Jeanne de Flandres Hospital, Lille, France.

Ute Moog (U)

Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.

Neslihan Onenli Mungan (NO)

Cukurova University Medical Faculty, Department of Pediatric Metabolism, Adana, Turkey.

Korbinian M Riedhammer (KM)

Institute of Human Genetics, Klinikum rechts der Isar, Technical University of Munich, Munich, Munich, Germany.
Institute of Human Genetics, Helmholtz Zentrum Munich, Neuherberg, Germany.
Department of Nephrology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

René Santer (R)

Department of Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Irene Valenzuela Palafoll (IV)

Department of Clinical Genetics and Molecular Genetics, Hospital Vall d'Hebron, Barcelona, Spain.

Jerry Vockley (J)

University of Pittsburgh School of Medicine, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA.

Dominik S Westphal (DS)

Institute of Human Genetics, Klinikum rechts der Isar, Technical University of Munich, Munich, Munich, Germany.
Institute of Human Genetics, Helmholtz Zentrum Munich, Neuherberg, Germany.

Arnaud Wiedemann (A)

Department of Pediatrics, INSERM 1256, Hôpital d'Enfants Brabois, CHU Nancy, Vandoeuvre les Nancy, France.

Saskia B Wortmann (SB)

Institute of Human Genetics, Klinikum rechts der Isar, Technical University of Munich, Munich, Munich, Germany.
Institute of Human Genetics, Helmholtz Zentrum Munich, Neuherberg, Germany.
Department of Pediatrics, Salzburger Landeskliniken and Paracelsus Medical University, Salzburg, Austria.

Gaurav D Diwan (GD)

CellNetworks, Bioquant, Heidelberg University, Heidelberg, Germany.
Biochemie Zentrum Heidelberg (BZH), Heidelberg University, Heidelberg, Germany.

Robert B Russell (RB)

CellNetworks, Bioquant, Heidelberg University, Heidelberg, Germany.
Biochemie Zentrum Heidelberg (BZH), Heidelberg University, Heidelberg, Germany.

Holger Prokisch (H)

Institute of Human Genetics, Klinikum rechts der Isar, Technical University of Munich, Munich, Munich, Germany.
Institute of Human Genetics, Helmholtz Zentrum Munich, Neuherberg, Germany.

Sven F Garbade (SF)

Division of Neuropediatrics and Pediatric Metabolic Medicine, Center for Child and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.

Stefan Kölker (S)

Division of Neuropediatrics and Pediatric Metabolic Medicine, Center for Child and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.

Georg F Hoffmann (GF)

Division of Neuropediatrics and Pediatric Metabolic Medicine, Center for Child and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.

Dominic Lenz (D)

Division of Neuropediatrics and Pediatric Metabolic Medicine, Center for Child and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany. Dominic.Lenz@med.uni-heidelberg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH